Related Experiment Video
Updated: Jun 11, 2025

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
A microbiome-directed therapeutic food for children recovering from severe acute malnutrition
Steven J Hartman1,2, Matthew C Hibberd1,2,3, Ishita Mostafa4
1Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Insights
A novel microbiome-directed complementary food (MDCF-2) significantly improved weight-for-length z-score in children with severe acute malnutrition (SAM). This intervention also positively impacted plasma proteins linked to development, suggesting a promising approach for malnutrition recovery.
Area of Science:
- Nutritional science and immunology
- Microbiome research
- Pediatric health
Background:
- Severe acute malnutrition (SAM) affects 14 million children under 5, with standard treatments often resulting in incomplete recovery.
- Children treated for SAM frequently transition to moderate acute malnutrition (MAM), indicating a need for more effective interventions.
- Understanding the interplay between nutrition, the microbiome, and host physiology is crucial for improving recovery outcomes.
Purpose of the Study:
- To evaluate the efficacy of a microbiome-directed complementary food (MDCF-2) compared to standard ready-to-use supplementary food (RUSF) in Bangladeshi children recovering from SAM.
- To investigate the impact of the intervention on plasma proteomic profiles and their association with anthropometric recovery.
- To explore the role of the gut microbiome, including specific bacterial strains, in mediating the effects of nutritional intervention.
Main Methods:
- A randomized controlled trial (RCT) involving 12- to 18-month-old Bangladeshi children treated for SAM.
- Intervention groups received either MDCF-2 or RUSF for 3 months post-hospitalization.
- Plasma protein levels and fecal microbiome composition were analyzed, alongside anthropometric measurements (weight-for-length z-score, WLZ).
Main Results:
- MDCF-2 treatment led to a significantly greater rate of WLZ improvement compared to RUSF (P = 8.73 × 10-3).
- Meta-analysis revealed 215 plasma proteins positively associated with WLZ, primarily related to musculoskeletal and CNS development, and 44 negatively associated proteins linked to immune activation.
- MDCF-2 significantly enriched the positively associated proteins (q = 1.1 × 10-6), and specific *Prevotella copri* strains were identified as key players in the microbiome's response to MDCF-2.
Conclusions:
- MDCF-2 demonstrates superior efficacy in promoting anthropometric recovery in children with SAM compared to standard interventions.
- The intervention modulates plasma protein profiles, suggesting a link between nutrition, the microbiome, and host development.
- Further research is warranted to confirm MDCF efficacy broadly and to identify biomarkers for treatment response.
Abstract:
Globally, severe acute malnutrition (SAM), defined as a weight-for-length z-score more than three SDs below a reference mean (WLZ < -3), affects 14 million children under 5 years of age. Complete anthropometric recovery after standard, short-term interventions is rare, with children often left with moderate acute malnutrition (MAM; WLZ -2 to -3). We conducted a randomized controlled trial (RCT) involving 12- to 18-month-old Bangladeshi children from urban and rural sites, who, after initial hospital-based treatment for SAM, received a 3-month intervention with a microbiome-directed complementary food (MDCF-2) or a calorically more dense, standard ready-to-use supplementary food (RUSF). The rate of WLZ improvement was significantly greater in MDCF-2-treated children (P = 8.73 × 10-3), similar to our previous RCT of Bangladeshi children with MAM without antecedent SAM (P = 0.032). A correlated meta-analysis of plasma levels of 4520 proteins in both RCTs revealed 215 positively associated with WLZ (largely representing musculoskeletal and central nervous system development) and 44 negatively associated (primarily related to immune activation). Moreover, the positively associated proteins were significantly enriched by MDCF-2 (q = 1.1 × 10-6). Characterizing the abundances of 754 bacterial metagenome-assembled genomes in serially collected fecal samples disclosed the effects of acute rehabilitation for SAM on the microbiome and how, during treatment for MAM, specific strains of Prevotella copri function at the intersection between MDCF-2 glycan metabolism and anthropometric recovery. These results provide a rationale for further testing the generalizability of MDCF efficacy and for identifying biomarkers to define treatment responses.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
What is Monogastric Digestion?

